Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

France: Servier acquires Day One Bio for US$2.5bn

M&A Nick Herbert -
France-headquartered Servier, an independent international pharmaceutical group governed by a foundation, has acquired Nasdaq-listed Day One Biopharmaceuticals, a biopharmaceutical company developing and commercialising targeted therapies for people of all ages with life-threatening diseases. The acquisition strengthens Servier’s position in low-grade glioma and in oncology with the addition of a...

From uncertainty to opportunity: life sciences dealmaking resets – Insights from McDermott Will & Schulte’s Life Sciences Symposium

Analysis Nick Herbert -
Against a backdrop of geopolitical tension, valuation resets and shifting capital markets, life sciences dealmaking is not slowing, it is recalibrating. The tone at McDermott Will & Schulte’s Life Sciences Symposium, held in Paris in March, reflected that shift. The message from across panels was consistent: uncertainty has not stalled dealmaking, it has reshaped it. Transaction structures are evolving, capital is becoming more selective, and strategic priorities are sharpening across pharma, biotech and healthcare services. “There is still a lot of activity,” says Emmanuelle Trombe, head of the Life Sciences Industry...